Align glutamyl-tRNA(Glx) synthetase (EC 6.1.1.24) (characterized)
to candidate WP_066551603.1 A4249_RS06190 glutamate--tRNA ligase
Query= reanno::Caulo:CCNA_01982 (470 letters) >NCBI__GCF_001636925.1:WP_066551603.1 Length = 471 Score = 580 bits (1494), Expect = e-170 Identities = 293/468 (62%), Positives = 356/468 (76%), Gaps = 3/468 (0%) Query: 1 MSNPTPTGVVTRFAPSPTGFLHIGGARTALFNWLYARHTGGKFLIRVEDTDRERSTEAAV 60 M++P+ T VVTRFAPSPTG+LHIGGARTALFNWLYA+ G+FLIRVEDTDRERST+ AV Sbjct: 1 MTSPSST-VVTRFAPSPTGYLHIGGARTALFNWLYAKRHAGRFLIRVEDTDRERSTDEAV 59 Query: 61 AAIFEGLDWLGLKSDDEVIFQHTRAPRHVEVVHELLAKGRAYRCWMSIEELEVAREKARA 120 AIF+GL WL L +DDE +FQ +RA RH EVV +LL G AYR + S EE R++A+A Sbjct: 60 KAIFDGLSWLELFADDEPVFQFSRADRHREVVDQLLETGHAYRDFNSAEETGRLRDEAKA 119 Query: 121 EGRAIRSPWRDAPE--GDLSAPHVIRFKGPLDGETLVNDLVKGPVTFKNIELDDLVLLRA 178 E R SPWRD DL+ PHV+RF+ P +V D V+G V++ +LDDLVLLR+ Sbjct: 120 EKRTFESPWRDREPTVDDLALPHVVRFRRPKATTVMVADEVQGDVSWSTEDLDDLVLLRS 179 Query: 179 DGAPTYNLAVVVDDHDMGVTHVIRGDDHLNNAARQTLIYQAMDWAVPAFAHIPLIHGPDG 238 DGAPTYNLAVVVDDHDMGVTHVIRGDDHLNNAARQ+LIY A+ W P FAHIPLIHGPDG Sbjct: 180 DGAPTYNLAVVVDDHDMGVTHVIRGDDHLNNAARQSLIYDALGWTRPTFAHIPLIHGPDG 239 Query: 239 AKLSKRHGAQAVGEFADLGYIPEGMRNYLARLGWGHGDDEVFTDEQAISWFDVADVVKAP 298 AKLSKRHGAQAV E+A++GY+PE MRNYLARLGW HGDDE+F+D QAI WFD+A + KAP Sbjct: 240 AKLSKRHGAQAVHEYAEMGYLPEAMRNYLARLGWSHGDDELFSDAQAIEWFDLAGIGKAP 299 Query: 299 ARLDWAKLNHINAQHLRKADDARLTALALAAAETRGEPLPADAAERIARTVPEVKEGAKT 358 ARLD+ KL H+N+ LR ADD RL L L A +G L R+ R +P VK+ AKT Sbjct: 300 ARLDFDKLAHVNSHWLRLADDERLAKLTLDAHLQKGHALAEADEARLQRAMPFVKDRAKT 359 Query: 359 ILELVDHCAFALKTRPLALEEKTQKQLTEETVERLKRLRDQLAAAPDFDAATLETVLKSF 418 IL+L D AF LK+RPL L++K + L+ ET+ERL RLR++L+ +D LE LK+F Sbjct: 360 ILDLADQTAFVLKSRPLTLDDKAKALLSGETLERLTRLRERLSLFQSWDVFALEAELKAF 419 Query: 419 AESEGVGFGKFGPALRGVLTGGAQAPDLNKTMAALSRDEAIGRLDDAL 466 AESEGVGFGK GP +R LT G+ +PD+ +T++AL RDE++GRLDDAL Sbjct: 420 AESEGVGFGKIGPPMRAALTAGSTSPDIARTLSALGRDESLGRLDDAL 467 Lambda K H 0.319 0.135 0.405 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 812 Number of extensions: 25 Number of successful extensions: 2 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 470 Length of database: 471 Length adjustment: 33 Effective length of query: 437 Effective length of database: 438 Effective search space: 191406 Effective search space used: 191406 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.7 bits) S2: 51 (24.3 bits)
This GapMind analysis is from Jul 25 2024. The underlying query database was built on Jul 25 2024.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory